Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anne-Lucie Nugues"'
Autor:
Yasmine Touil, Céline Latreche‐Carton, Hassiba El Bouazzati, Anne‐Lucie Nugues, Nathalie Jouy, Xavier Thuru, William Laine, Frederic Lepretre, Martin Figeac, Meryem Tardivel, Jérôme Kluza, Thierry Idziorek, Bruno Quesnel
Publikováno v:
Journal of Cellular Biochemistry
Journal of Cellular Biochemistry, 2022, 123 (3), pp.543-556. ⟨10.1002/jcb.30198⟩
Journal of Cellular Biochemistry, 2022, 123 (3), pp.543-556. ⟨10.1002/jcb.30198⟩
International audience; Receptor-interacting protein kinase 3 (RIPK3) can induce necroptosis, apoptosis, or cell proliferation and is silenced in several hematological malignancies. We previously reported that RIPK3 activity independent of its kinase
Publikováno v:
Cancer Letters. 366:32-43
Inhibitor of Apoptosis (IAP) proteins are expressed at high levels in acute myeloid leukemia (AML) and contribute to resistance to programmed cell death. Here, we report that inhibition of IAP proteins by the small-molecule Smac mimetic BV6 acts toge
Autor:
Marc R. Mansour, Ming Wei, Heinz Lubenau, Sébastien Wieckowski, Lilli Podola, Philipp Beckhove, Amine Adda Berkane, Philippe Slos, Klaus M. Breiner, Anne-Lucie Nugues, Albrecht Meichle, Heiko Smetak
Publikováno v:
Cancer Research. 78:733-733
Significant progresses have been achieved recently in cancer vaccines that aim at engaging or reengaging tumor directed T cells, in particular in the rapidly growing field of personalized immunotherapy. Yet novel immunization solutions to produce eff
Autor:
Philippe Slos, Amine Adda Berkane, Marc R. Mansour, Anne-Lucie Nugues, Klaus M. Breiner, Albrecht Meichle, Philipp Beckhove, Ming Wei, Iris Kobl, Lilli Podola, Sébastien Wieckowski, Matthias Schroff, Heinz Lubenau, Heiko Smetak
Publikováno v:
Journal of Clinical Oncology. 36:74-74
74 Background: Significant progresses have been recently achieved in cancer vaccines, yet novel immunization solutions to deliver efficiently tumor-associated antigens to professional antigen-presenting cells, and to overcome the peripheral tolerance
Autor:
Matthias Schroff, Beckhove Philipp, Klaus M. Breiner, Lilli Podola, Heiko Smetak, Heinz Lubenau, Marc Mansour, Albrecht Meichle, Ming Wei, Sébastien Wieckowski, Anne-Lucie Nugues, Philippe Slos, Marco Springer, Iris Kobl, Amine Adda Berkane
Publikováno v:
Molecular Cancer Therapeutics. 17:B196-B196
Significant progress has been achieved recently in cancer vaccines that aim at engaging or reengaging the tumor immunity, in particular in the rapidly growing field of personalized immunotherapy. Yet novel immunization solutions to deliver efficientl
Autor:
Bruno Quesnel, Anne-Lucie Nugues, Anne Loyens, Céline Berthon, Dominique Hetuin, Thierry Idziorek, Elisabeth Bertrand, Hassiba Bouafia, Nathalie Jouy
Publikováno v:
Cancer Research. 74:1342-1342
Introduction. Impairment in cell death pathways represents a general characteristic of most cancer cells. The receptor-interacting protein kinase 3 (RIP3) associates with RIP1 in a necrosome complex that can induce necroptosis, apoptosis, or cell pro